1. Home
  2. NNNN vs CECO Comparison

NNNN vs CECO Comparison

Compare NNNN & CECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • CECO
  • Stock Information
  • Founded
  • NNNN 2021
  • CECO 1966
  • Country
  • NNNN Germany
  • CECO United States
  • Employees
  • NNNN N/A
  • CECO N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • CECO Pollution Control Equipment
  • Sector
  • NNNN Health Care
  • CECO Industrials
  • Exchange
  • NNNN Nasdaq
  • CECO Nasdaq
  • Market Cap
  • NNNN 2.2B
  • CECO 1.7B
  • IPO Year
  • NNNN 2025
  • CECO N/A
  • Fundamental
  • Price
  • NNNN $27.36
  • CECO $48.58
  • Analyst Decision
  • NNNN
  • CECO Strong Buy
  • Analyst Count
  • NNNN 0
  • CECO 4
  • Target Price
  • NNNN N/A
  • CECO $47.50
  • AVG Volume (30 Days)
  • NNNN 39.8K
  • CECO 556.7K
  • Earning Date
  • NNNN 04-28-2026
  • CECO 10-28-2025
  • Dividend Yield
  • NNNN N/A
  • CECO N/A
  • EPS Growth
  • NNNN N/A
  • CECO 334.15
  • EPS
  • NNNN 0.06
  • CECO 1.43
  • Revenue
  • NNNN $8,185,146.00
  • CECO $718,253,000.00
  • Revenue This Year
  • NNNN N/A
  • CECO $39.21
  • Revenue Next Year
  • NNNN N/A
  • CECO $13.44
  • P/E Ratio
  • NNNN $503.50
  • CECO $33.98
  • Revenue Growth
  • NNNN 21.95
  • CECO 29.86
  • 52 Week Low
  • NNNN $5.18
  • CECO $17.57
  • 52 Week High
  • NNNN $55.65
  • CECO $56.19
  • Technical
  • Relative Strength Index (RSI)
  • NNNN 54.26
  • CECO 43.64
  • Support Level
  • NNNN $12.93
  • CECO $51.20
  • Resistance Level
  • NNNN $25.20
  • CECO $50.30
  • Average True Range (ATR)
  • NNNN 4.99
  • CECO 2.52
  • MACD
  • NNNN 1.61
  • CECO -0.61
  • Stochastic Oscillator
  • NNNN 73.40
  • CECO 24.25

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About CECO CECO Environmental Corp.

CECO Environmental Corp serves the energy, industrial, and other niche markets. The company operates through the Engineered Systems segment that serves the power generation, refinery, water/wastewater, and midstream oil and gas markets, and Industrial Process Solutions segment, which serves the broad industrial air pollution control, beverage can, fluid handling, electric vehicle production, food and beverage, semi-conductor, process filtration, pharmaceutical, petrochemical, wastewater treatment, wood manufacturing, desalination, and aquaculture markets. The majority of revenue is earned from the Engineered Systems Segment.

Share on Social Networks: